AzTrials
AzTrials

Tooth ExtractionNCT06657651

IMMEDIATE IMPLANT With Different Types of Membranes

A study testing immediate implant placement with dentin-derived membrane and immediate implant with extended platelet rich fibrin membrane in people with Tooth Extraction, run by Mansoura University at 1 site in Egypt.

Enrolling by invitation

Enrolling by invitation. The study team selects and invites participants, usually from an existing group of patients.

Sites and contacts
Official record

Search all trials

Trial summary

forty patients will be selected from the outpatient's clinic of Oral and Maxillofacial Surgery Department, Faculty of Dentistry, Mansoura University for replacement of non-restorable tooth in posterior mandibular area. Read more about this study

Who is it for?
Ages 18 to 60 yearsHealthy volunteers can take part
Conditions the study is for
Tooth Extraction
What is being tested?
immediate implant placement with dentin-derived membrane and immediate implant with extended platelet rich fibrin membrane
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteEgypt
Study dates
30 Jun 2024to 1 Jun 2025
Phase
Interventional

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Age above 18 years
  • Non-restorable mandibular molar tooth that needs dental extraction \& guided bone regeneration for immediate implant placement.
  • Acceptable inter-arch space for the future prosthesis.
  • Patient medically free from systemic diseases that absolutely contraindicate implant surgery.
  • Cooperative patient with high motivation and acceptable oral hygiene.
  • Free from history of bruxism / parafunctional habits.

Who cannot join

  • Local and / or systemic conditions that interfere with the procedure.
  • Smokers.
  • Pregnancy.
  • Uncooperative patients.
  • Patient had undergone in the past 12 months radiation therapy to the head and neck area.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Egypt1 site
  • Heba Elsheikh

    Al Mansurah

Other trials in Egypt

About this study

Official title: Autogenous Dentine Derived Barrier Membrane Versus Extended Platelet Rich Fibrin Membrane in Immediate Implant Placement

forty patients will be selected from the outpatient's clinic of Oral and Maxillofacial Surgery Department, Faculty of Dentistry, Mansoura University for replacement of non-restorable tooth in posterior mandibular area.

Patients' Grouping:

Read more

The patients will be randomly divided into two equal uniform groups each consists of 20 patients:

Group A:

20 patients with non-restorable mandibular molar tooth will be treated with an immediately placed dental implant in conjunction with a dentin-derived membrane from the extracted tooth.

Group B:

20 patients with non-restorable mandibular molar tooth will be treated with an immediately placed dental implant in conjunction with extended platelet rich fibrin membrane.

Being tested
immediate implant placement with dentin-derived membrane, immediate implant with extended platelet rich fibrin membrane

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • immediate implant placement with dentin-derived membraneProcedure or surgery

    immediate implant placement with dentin-derived membrane and allograft in mandibular molar area

  • immediate implant with extended platelet rich fibrin membraneProcedure or surgery

    immediate implant with extended platelet rich fibrin membrane and allograft in mandibular molar area

Study groups in NCT06657651
Study groupRoleWhat they receive
immediate implant with dentin-derived membraneExperimentalNot described
Receives: Procedure: immediate implant placement with dentin-derived membrane
immediate implant with extended platelet rich fibrin membraneExperimentalNot described
Receives: Procedure: immediate implant with extended platelet rich fibrin membrane

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Implant stability

    Osstell will be used to record implant stability at the placement time, 3, 6 and 12 months after surgery.

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Oct 2024
  2. Study start30 Jun 2024
  3. Primary completion1 Mar 2025 (estimated)
  4. Study completion1 Jun 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06657651
Sponsor's protocol ID
A06030240S
Status last verified
Oct 2024
First submitted
23 Oct 2024
Last updated
28 Oct 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in